enGene, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve (NCT04752722) | enGene, Inc. | 2021-04-22 |
Track enGene, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.